Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Generics [UK] Ltd t/a Mylan, Station Close, Potters Bar, Herts, EN6 1TL
Nizatidine 150 mg Capsules, hard.
| Pharmaceutical Form |
|---|
|
Capsule, hard. Hard gelatin capsules containing white to off-white powder with a light yellow body and dark yellow cap. The body has “NZ 150” and the cap has “G”, both printed in black. |
Each capsule contains 150 mg of nizatidine.
Excipient with known effect: Each capsule contains Allura red.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Nizatidine |
Nizatidine is a potent, selective, competitive and fully reversible histamine H2-receptor antagonist. Nizatidine significantly decreased basal and stimulated gastric acid and pepsin concentration, in addition to the volume of gastric secretion. |
| List of Excipients |
|---|
|
Capsule Contents: Croscarmellose sodium Capsule Composition: Titanium dioxide (E171) Ink Composition: Shellac |
High density polyethylene bottles with polypropylene snap-on caps containing 28 or 30 capsules or PVC/Aluminium blister packs containing 28 or 30 capsules.
Not all pack sizes may be marketed.
Generics [UK] Ltd t/a Mylan, Station Close, Potters Bar, Herts, EN6 1TL
PL 04569/0471
Date of first authorisation: 17/07/2002
Date of latest renewal: 12/03/2009
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
